Sometimes people with MS can get dramatically worse after stopping certain types of disease modifying therapies known as immunosequestrants (such as Tysabri, gilenya, mayzent, zeposia). This video discusses the phenomenon of “rebound” disease activity and reviews the risk factors and treatment references: